CG Oncology (CGON) Leases (2023 - 2025)
CG Oncology's Leases history spans 3 years, with the latest figure at $4.0 million for Q4 2025.
- For Q4 2025, Leases rose 1696.83% year-over-year to $4.0 million; the TTM value through Dec 2025 reached $4.0 million, up 1696.83%, while the annual FY2025 figure was $4.0 million, 1696.83% up from the prior year.
- Leases reached $4.0 million in Q4 2025 per CGON's latest filing, down from $4.2 million in the prior quarter.
- In the past five years, Leases ranged from a high of $4.2 million in Q3 2025 to a low of $221000.0 in Q4 2024.
- Average Leases over 3 years is $1.3 million, with a median of $422000.0 recorded in 2023.
- Peak YoY movement for Leases: crashed 47.63% in 2024, then soared 1696.83% in 2025.
- A 3-year view of Leases shows it stood at $422000.0 in 2023, then plummeted by 47.63% to $221000.0 in 2024, then skyrocketed by 1696.83% to $4.0 million in 2025.
- Per Business Quant, the three most recent readings for CGON's Leases are $4.0 million (Q4 2025), $4.2 million (Q3 2025), and $965000.0 (Q2 2025).